Inscription Capital LLC Buys Shares of 3,426 Aflac Incorporated (NYSE:AFL)

Inscription Capital LLC purchased a new stake in Aflac Incorporated (NYSE:AFL - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 3,426 shares of the financial services provider's stock, valued at approximately $381,000.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. grew its stake in shares of Aflac by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider's stock worth $5,310,640,000 after purchasing an additional 653,275 shares in the last quarter. Geode Capital Management LLC raised its holdings in Aflac by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 12,465,433 shares of the financial services provider's stock worth $1,286,042,000 after purchasing an additional 288,482 shares in the last quarter. Northern Trust Corp raised its holdings in Aflac by 22.9% during the fourth quarter. Northern Trust Corp now owns 7,296,014 shares of the financial services provider's stock worth $754,700,000 after purchasing an additional 1,357,753 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Aflac by 11.9% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,250,905 shares of the financial services provider's stock worth $543,154,000 after buying an additional 556,394 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Aflac in the 4th quarter valued at $349,699,000. Hedge funds and other institutional investors own 67.44% of the company's stock.

Aflac Price Performance

Shares of Aflac stock traded up $0.47 on Thursday, hitting $102.56. The company's stock had a trading volume of 2,127,289 shares, compared to its average volume of 2,111,025. The company has a quick ratio of 0.09, a current ratio of 0.09 and a debt-to-equity ratio of 0.29. The firm has a fifty day moving average price of $105.02 and a 200-day moving average price of $105.35. Aflac Incorporated has a 52-week low of $88.00 and a 52-week high of $115.50. The company has a market capitalization of $55.45 billion, a P/E ratio of 16.02, a price-to-earnings-growth ratio of 3.18 and a beta of 0.82.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The company had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. During the same period in the previous year, the business earned $1.66 EPS. The firm's revenue was down 37.5% on a year-over-year basis. On average, equities research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were given a $0.58 dividend. The ex-dividend date was Wednesday, May 21st. This represents a $2.32 annualized dividend and a dividend yield of 2.26%. Aflac's dividend payout ratio is presently 36.25%.

Insider Buying and Selling at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $106.79, for a total value of $106,790.00. Following the completion of the transaction, the director now owns 26,096 shares of the company's stock, valued at approximately $2,786,791.84. This represents a 3.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the transaction, the director now owns 70,992 shares in the company, valued at $7,496,045.28. This trade represents a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 40,750 shares of company stock worth $4,304,295 in the last quarter. 0.90% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on AFL. Wells Fargo & Company boosted their price target on shares of Aflac from $102.00 to $103.00 and gave the company an "equal weight" rating in a research report on Tuesday, May 6th. UBS Group lifted their target price on Aflac from $109.00 to $114.00 and gave the stock a "neutral" rating in a research report on Wednesday, April 2nd. Morgan Stanley upped their target price on Aflac from $100.00 to $105.00 and gave the company an "equal weight" rating in a research report on Monday, May 19th. Piper Sandler lifted their price target on Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Finally, JPMorgan Chase & Co. boosted their price objective on Aflac from $94.00 to $96.00 and gave the company a "neutral" rating in a research note on Wednesday, April 2nd. Three investment analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $104.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.